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The detection and processing of novelty plays a critical role in memory function. Despite this, 
relatively little is known about how novelty influences memory in Alzheimer's disease (AD). 
This review sought to address whether AD patients are still sensitive to novelty; whether 
novelty triggers memory processes as is observed in healthy subjects; and whether it is 
possible to promote novelty to enhance memory at the different stages of AD. The studies 
reviewed showed that novelty processing is mostly impaired in AD patients, whereas it can be 
preserved under some conditions in MCI, particularly when cognitive demands are otherwise 
low. We further identify outstanding questions that should be addressed in the near future in 
order to more robustly establish the fate of novelty processing and detection in the course of 
AD. Doing so would allow to improve current models of memory impairment in AD, leading 
to a more comprehensive view of the sources of memory decline and could lead to 
neuropsychological and/or pharmaceutical rehabilitation programs. 
 
 





Novelty processing and memory impairment in Alzheimer’s disease: a review 
 
1. Introduction 
Novelty processing is a fundamental cognitive ability governing a wide range of behaviours 
including curiosity, motivation, attention and memorization. It is particularly important for 
learning (Tulving and Kroll, 1995); by definition, learning concerns novel facts and situations. 
An efficient memory intrinsically relies on an interplay between what is detected to be novel 
and what is known to be familiar (van Kesteren et al., 2012). 
In Alzheimer’s disease (AD), many studies have been devoted to the study of memory. 
Intriguingly however, very little work has been carried out on how patients with AD process 
novelty, and virtually none regarding how novelty processing relates to their memory 
impairment. This is a critical oversight since impaired novelty processing could add to 
accounts of the severe memory impairment observed in AD. Otherwise, manipulating novelty 
at encoding could potentially be an effective cognitive technique to facilitate learning in 
patients suffering from AD, especially in the predementia stage of Mild Cognitive Impairment 
(MCI, Albert et al., 2011). Thus, a better understanding of novelty processing in AD could 
open up new avenues for rehabilitation programs. 
In this review article, we first succinctly describe what novelty is and how it is a 
critical component of the memory system. Following this, we review whether novelty is 
preserved or impaired in the course of AD. We then summarize outstanding questions in the 
field that ought to be investigated in the near future and end up with a novel model of the 
memory impairment observed in AD. We focus throughout this review along three main 
questions which are to our knowledge currently entirely unresolved: do patients with AD or 
MCI still detect novelty? Does novelty detection improve memory as is usually the case in 
healthy subjects? Is it possible to use novelty to enhance memory in AD? Our emphasis is that 
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a better understanding of novelty processing in the course of AD is a milestone to a more 
complete apprehension of the nature of memory impairment in this population. 
 
2. What is novelty?  
2.1 Definition 
Detection and processing of novel information can take different forms depending on the 
particular case in which it occurs (see Table 1 for definitions). Previous articles have 
differentiated novelty from deviance and surprise (e.g. Schomaker and Meeter, 2015) and we 
briefly differentiate these concepts in Table 1. The most frequently studied forms of novelty 
are stimulus —contextual— and associative novelty. 
 
2.1.1 Stimulus novelty 
Stimulus novelty refers to stimuli that have never been experienced before (Kumaran and 
Maguire, 2007b), such as new individual objects, fractals or objects that are difficult to 
categorize (Schomaker and Meeter, 2015). Such events typically elicit an orienting response 
of attentional resources towards novel information (Corbetta and Shulman, 2002). When a 
stimulus is repeated, this induces behavioural and neural changes (Ranganath and Rainer, 
2003). Behavioural repetition-induced changes are visible through priming effects, 
corresponding to faster and more efficient processing of repeated stimuli compared with novel 
ones. Moreover, cortical and subcortical neural activity is reduced when stimuli are repeated 
(i.e. repetition suppression effect, Grill-Spector et al., 2006; Nyberg, 2005; Ranganath and 
Rainer, 2003). 
Novelty is thought to elicit a learning signal such that the novelty of a stimulus 
promotes learning (Tulving and Kroll, 1995). Consistently, novelty has been shown to 
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enhance subsequent memory compared to stimuli that were previously familiarized (see for 
example the Von Restorff effect described below). 
 
2.1.2 Contextual novelty 
Contextual novelty represents the novelty of a familiar stimulus that is unexpected given the 
context in which it occurs (Kumaran and Maguire, 2007b; Nyberg, 2005; Ranganath and 
Rainer, 2003), for instance because it differs from other stimuli shown in the context 
(Schomaker and Meeter, 2015). Some authors propose that distinctiveness (i.e., when stimuli 
stand out from others in a series) is linked to contextual novelty (Poppenk et al., 2010a; 
Tulving and Rosenbaum, 2006). Another related phenomenon is deviance; a stimulus 
belonging to an infrequent category that is dissimilar from the category of other stimuli 
(Schomaker and Meeter, 2015). 
Contextually novel or distinct events tend to be encoded more efficiently than less 
novel ones or items that do not stand out (Ranganath and Rainer, 2003; Tulving and 
Rosenbaum, 2006). Contextual novelty also contributes to the ‘primacy effect’ described in 
the memory literature, where items that are presented first in a study list are better 
remembered than items that are presented later in the list. According to Davelaar (2013), the 
first two or three items of a list are distinctive due to increase in the change within a 
distributed episodic context representation, thereby creating contextual novelty. 
  
2.1.3 Associative novelty 
Associative novelty occurs when the combination or configuration of two or several familiar 
stimuli is novel (Nyberg, 2005). Kumaran and Maguire (2007b) defined three types of 
associative novelty. In spatial novelty, familiar items appear in a new spatial location. In 
temporal or sequence novelty, familiar items are presented in a new temporal order. Finally, 
 6 
in “item-item” novelty, familiar items appear together in a new combination (e.g., 
recombinations in an associative recognition memory task, consisting of two previously 
studied items that initially appeared in different pairings).  
  
2.1.4 Other types of novelty 
Schomaker and Meeter (2015) defined additional types of novelty. Notably, 
spatial/environmental novelty refers to the novelty of an environment rather than of a 
stimulus, and surprise/unexpectedness refers to events that violate expectancies, due to 
deviations from explicit predictions (e.g., unpredicted action effects) (see also Henson and 
Gagnepain, 2010). Although the concept of surprise – together with the one of deviance – is 
readily dissociable from novelty, they tend to be confounded in the experimental assessment 
of novelty, so that it is not clear which aspect – novelty, deviance, or surprise – actually elicits 
neural responses usually ascribed to novelty (Schomaker and Meeter, 2015). 
 
2.2 Assessment methods 
Several experimental paradigms are commonly used to assess either novelty detection or the 
influence of novelty on memory. 
 
2.2.1 Stimulus novelty detection 
Visual paired comparison task 
The amount of time spent looking at a stimulus, the number of fixations as well as a 
quantification of exploratory eye movements are all influenced by the detection of novelty 
and are thought to represent the allocation of attentional resources towards novelty and 
exploration of novel information (Daffner et al., 1992, 1994, 2001, 2007; Yeung et al., 2017). 
A common paradigm, the visual paired comparison task, consists of assessing how much time 
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is spent on a novel stimulus when it is presented simultaneously with a familiar one. Usually, 
a longer fixation time is found for the novel stimulus. Pupil constriction has also been shown 
to accompany novelty detection (Kafkas and Montaldi, 2015; Vo et al., 2008) and to predict 
successful memory for novel stimuli (Naber et al., 2013). 
 
2.2.2 Contextual novelty detection 
Oddball paradigm 
The detection of contextual novelty can be assessed using the oddball paradigm (see Figure 
1). In this paradigm, subjects perform a target detection task in which 60% to 80% of the trials 
are repeated standard stimuli, 10% to 20% are infrequent to-be-detected targets (the 
‘oddballs’), and 10% to 20% are infrequent distracters, presented in a random sequence. 
Participants usually have to detect the oddball stimuli as quickly as possible. This paradigm 
typically induces an orienting attentional response towards contextually novel stimuli. It can 
be seen in the associated event-related potentials (ERPs): oddballs correctly detected generate 
a parietal-maximum P300 (P3b), while infrequent non-target stimuli requiring no behavioural 
response elicit a fronto-central P300 (P3a) (for a review see Polich, 2007; Yamazaki et al., 
2001). 
 
2.2.3 Novelty-related memory effects 
Von Restorff paradigm 
In the von Restorff paradigm, one deviant or distinctive item (so-called “the isolate”) is 
studied among a group of relatively homogeneous items (the distinction can be made along 
any dimension such as size, font, colour, emotional content, or semantic category) (Hunt, 
1995; Nyberg, 2005; Vitali et al., 2006). The paradigm assesses the impact of contextual 
novelty on memory for the contextually novel items as compared to memory for non-
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distinctive items (Von Restorff, 1933) (see Figure 1). The isolates are usually better recalled 
or recognized than control stimuli. Currently, the preferred explanations for this effect are the 
distinctiveness hypothesis according to which the isolate stands out against the similarity of 
other items (Hunt, 2013) and the retrieval cue hypothesis that assumes that the isolate is more 
easily retrieved because retrieval cue specifies only a single target contrary to control items 
that are all candidate targets, thus leading to more interference (Nairne, 2006). 
 
Novelty system activation 
Novelty is thought to activate a cascade of neural processes, including activation of the 
dopaminergic system (see below), facilitating encoding, that lasts up to 10 minutes after the 
novel information has been presented. New paradigms have been developed on this idea that 
exposure to novelty facilitates new learning. These paradigms generally expose participants to 
novelty, then have them study new information. Such paradigms have been shown to improve 
subsequent memory for information learnt after an exposure to novelty compared with 
performance after exposure to familiar information (e.g., Fenker et al., 2008; Schomaker et 
al., 2014).  
 
Pre-experimental familiarity vs novelty effect 
The impact of novelty on memory encoding and retrieval can be otherwise assessed by 
manipulating pre-exposure versus novelty of the stimuli to be encoded in a memory task 
(Aberg and Nilsson, 2001, 2003; Kormi-Nouri et al., 2005; Tulving and Kroll, 1995). 
Typically, in such paradigms, recognition of novel words is contrasted with recognition of 
words that have been familiarized through repetition before the actual encoding phase 
(Tulving and Kroll, 1995). Variants of this procedure exist with various types of materials 
such as proverbs (Poppenk et al., 2010a). 
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2.3 Cognitive models of novelty processing and memory 
Several models have been proposed to account for the computations triggering novelty 
signals, depending on the type of novelty.  
 
2.3.1 Stimulus novelty 
Some models assimilate novelty detection with familiarity detection (i.e. familiarity-based 
recognition memory), in such a way that familiarity and novelty detection processes can be 
considered as two ends of a single continuum drawing on the same cognitive mechanism 
(Brown and Bashir, 2002; Fernandez and Tendolkar, 2006; Grill-Spector et al., 2006; Horner 
et al., 2012). These models propose a rapid novelty/familiarity discrimination system and are 
based on the notion of repetition priming and repetition suppression at a neural level. 
Alternatively, Kafkas and Montaldi (2014, 2015) posit a ‘dual-route with 
convergence’ recognition memory mechanism in which novelty and familiarity produce 
distinct signals that stem from distinct processing pathways, that subsequently converge to 
produce a unitary relative-familiarity signal behaving as expected from a familiarity-novelty 
continuum despite distinct upstream processing paths. In support, an fMRI study showed 
familiarity and novelty in distinct brain regions in an initial phase, with subsequent common 
neural bases processing familiarity and novelty as one unitary mechanism (Kafkas and 
Montaldi, 2014). 
 
2.3.2 Contextual novelty 
In the case of contextual novelty, some models proposed that it relies on a comparator 
mechanism between prior expectations and experience (also named match-mismatch models 
(Kumaran and Maguire, 2007a, 2009)) to explain the computation of novelty signals (see also 
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Henson and Gagnepain, 2010; Lisman and Grace, 2005; Ratcliff, 1978). These models 
generally consider that a given input is compared to stored memories. Recognition (or 
familiarity) happens as soon as the input item finds a match in stored representations. Novelty 
detection will only be triggered once the entire store of representations has been looked over 
without finding any corresponding match. This implies waiting until the slowest comparisons 
terminate to take a novelty decision. Importantly, these models predict that the mechanism of 
novelty detection is distinct from and slower than the mechanism of familiarity. This class of 
models, as well as the familiarity/novelty discrimination system and the ‘dual-route with 
convergence’ model are schematized in Figure 2. None of these models receives unanimous 
support, and only a few experiments have directly compared familiarity to novelty detection 
(e.g., Delhaye et al., 2017). 
 
It seems important to note that novelty detection and processing are moreover 
modulated by a series of cognitive processes such as for instance phasic alertness that allow 
one to orient one’s attention towards novel stimuli. Thus, the integrity of such processes are a 
prerequisite for efficient novelty processing.  
 
2.4 Neural bases of novelty 
The detection of novelty and novelty-related memory effects rely on a large-scale cerebral 
network, in which the hippocampus and other temporal lobe structures, the prefrontal cortex 
and the substantia nigra/ventral tegmental area play a crucial role (Ranganath and Rainer, 
2003). Neuropsychological studies have pointed to the need for intact hippocampal structures 
and the prefrontal cortex in order to be able to process novelty. More precisely, there is 
functional specialization within the MTL, with some regions being more sensitive to certain 
kinds of novelty. The middle hippocampus would react to associative novelty, whereas the 
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perirhinal cortex is specifically activated by stimulus novelty (Kohler et al., 2005) or lack of 
familiarity (Kafkas and Montaldi, 2018). The amygdala was also found to respond to novel 
unusual stimuli (Blackford et al., 2010). 
 
2.4.1 Stimulus novelty detection 
Hippocampal lesions were shown to disrupt the preference for novelty in visual paired 
comparison tasks (Munoz et al., 2011; Pascalis et al., 2004). Moreover, focal lesions to the 
prefrontal cortex impair the ability to detect the novelty of a stimulus in a memory task 
(Bastin et al., 2006; Schacter et al., 1996) and disrupt attention towards novel events, as 
demonstrated by reduced viewing time for novel items compared to controls and diminished 
P3 amplitude (Daffner et al., 2000a, 2000b). Neuronal recordings also indicate neurons 
responding specifically to novel stimuli in the perirhinal cortex. These neurons have relatively 
short latencies and are intermixed in the perirhinal cortex with other neurons coding for 
familiarity and recency (Xiang and Brown, 1998). Neurons coding for novelty (and 
familiarity) have also been identified in the human hippocampus (Rutishauser et al., 2006).  
 
2.4.2 Contextual novelty detection 
The hippocampus shows robust, large, ERPs specifically induced by target stimuli during 
oddball paradigms (Halgren et al., 1980; McCarthy et al., 1989) (Figure 3). The source of 
these ERPs is more precisely thought to originate from the CA1 region (Barbeau et al., 2017; 
Brankack and Buzsaki, 1986). Interestingly, these ERPs are induced only when participants 
specifically pay attention to the out-of-context target (endogenous attention) (Barbeau et al., 
2017), indicating that the hippocampus is involved in novelty when it is processed explicitly. 
The activation of the hippocampus during oddball tasks is also shown using fMRI, with visual 
and auditory stimuli (Crottaz-Herbette et al., 2005). In contrast, the perirhinal cortex does not 
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present any specific activity during oddball tasks, demonstrating that the hippocampus plays a 
special role with regard to the processes at play during oddball tasks. Oddball tasks also 
induce novelty responses in many other brain areas as shown by intracranial recordings in the 
human (Halgren et al., 1998) and fMRI (Yamaguchi et al., 2004). Notably, a change in a 
series of sensory stimulation elicits activation of a network involving the temporoparietal 
junction, inferior frontal gyrus, insula, cingulate and supplementary motor areas (Downar et 
al., 2000), reflecting an attention orienting response (Corbetta and Shulman, 2002). In 
addition, stimulus novelty, associative novelty and environmental novelty activate the 
substantia nigra/ventral tegmental area (Bunzeck and Duzel, 2006; Fenker et al., 2008; Schott 
et al., 2004), a key region for dopaminergic neuromodulation. 
 
2.4.3 Novelty-related memory effect 
With regard to the novelty-related memory effect, a central role seems again to be played by 
the medial temporal lobe (MTL). Notably, neuropsychological studies have shown that 
hippocampal lesions reduce the novelty-related memory benefit (Kishiyama et al., 2004). 
Novelty triggers a response in the anterior part of the hippocampus, which decreases with 
repetition (Kumaran and Maguire, 2006, 2007a; Strange and Dolan, 2001; Strange et al., 
2005). Additionally, the MTL is consistently activated when participants process novel 
stimuli in memory tasks, both at encoding (Habib et al., 2003; Kirchhoff et al., 2000; Poppenk 
et al., 2010b; Stern et al., 1996) and at retrieval (de Chastelaine et al., 2017; Kafkas and 
Montaldi, 2015; Poppenk et al., 2008; Tulving et al., 1996). Moreover, the specific MTL 
regions that react to novelty appear to differ from the MTL regions supporting recollection 
and familiarity in some studies (Daselaar et al., 2006). 
Activation of the ventrolateral prefrontal cortex and lateral temporal cortex during 
encoding of novel items predict subsequent memory for these items (Fenker et al., 2008; 
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Kirchhoff et al., 2000; Poppenk et al., 2010b; Reggev et al., 2016), suggesting that these 
regions contribute to efficient encoding of novel items. However, because they also predict 
subsequent memory when contextual novelty is held constant (Kirchhoff et al., 2000), this 
likely reflects the role of these regions in encoding in general (Badre and Wagner, 2002; 
Thompson-Schill et al., 1997). Moreover, the occurrence of an unexpected novel item during 
a recognition memory task activates the substantia nigra/ventral tegmental area, and enhances 
functional connectivity between this region and the hippocampus (Kafkas and Montaldi, 
2015), indicating an interplay between the hippocampus and the dopaminergic system. 
 
2.5 Neurobiological models of novelty processing 
An important neurobiological model relating novelty and memory has been put forward by 
Lisman and Grace (see also Duzel et al., 2010; Lisman and Grace, 2005) (Figure 4). The 
authors suggest that a loop between the hippocampus and the ventral tegmental area (VTA) 
facilitates encoding of new information. The general idea behind that model is that the CA1 
region of the hippocampus compares predictions made through the tri-synaptic and CA3 
pathway to the hippocampus and sensory reality arriving to CA1 through the monosynaptic 
direct pathway. In the case of a novel event, a novelty signal activates the VTA through the 
accumbens nucleus and ventral pallidum. The VTA in turn activates dopamine release in CA1 
facilitating late long-term potentiation (LTP). Finally, entry of novel information into long 
term memory is regulated as a function of goal-related motivation and salience information 
(i.e., whether the object is behaviourally relevant), and this function is provided by the 
prefrontal cortex and limbic areas, so that the memory system only encodes important novel 
information. This model has been subsequently refined (Lisman et al., 2011; Otmakhova et 
al., 2013) and is supported by fMRI activation studies which have related the activation of the 
dopaminergic system with better memory (Wittmann et al., 2005, 2007). In a recent study in 
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human patients, Kaminski et al. (2018) recorded the activity of individual neurons in the 
substantia nigra and identified dopaminergic neurons that were sensitive to the novelty of 
stimuli. According to Kafkas and Montaldi (2018), this hippocampal-VTA dopaminergic loop 
specifically supports the detection and encoding of contextually novel stimuli. In contrast, 
stimulus novelty triggers directly acetylcholine-mediated encoding in the hippocampus.  
 
3. Novelty in Alzheimer’s disease: impaired or preserved? 
3.1 Physiopathology of Alzheimer’s disease 
AD is the most common form of brain pathology leading to cognitive impairment in the adult, 
affecting as many as 8 percent of the population around 70 years of age (World Health 
Organization). It is a complex neuropathological disease characterized by the accumulation of 
beta-amyloid and abnormally phosphorylated tau proteins in the brain (Selkoe and Hardy, 
2016). These lead to a cascade of synaptic and LTP changes, neuronal death and a variety of 
cognitive impairments taking place over the course of several decades (Braak et al., 2011; 
Jack et al., 2013; Sutphen et al., 2015). Consequently, several stages have been identified, 
including a preclinical, asymptomatic stage (characterized by the presence of biomarkers 
indicating amyloidosis in the brain using PET or CSF analyses in cognitively healthy 
individuals), a prodromal stage (early, symptomatic, predementia stage of AD, characterized 
by MCI) and a dementia stage (Dubois et al., 2010). 
Amyloidosis appears to diffuse in the brain from the onset of the disease and may 
impact memory networks early-on (Sperling et al., 2014). Neurofibrillary tangles occur first in 
more circumscribed regions, such as in the brainstem and in MTL structures, most notably, in 
the entorhinal and perirhinal cortices before reaching the hippocampus (Braak and Braak, 
1995; Braak et al., 2011). Changes in MTL structures involve neuronal death, atrophy of 
subhippocampal and hippocampal structures and progressive memory decline at the onset of 
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the prodromal stage (Dubois et al., 2014). More specifically, dysfunctional familiarity-based 
memory has been associated with volume loss in the perirhinal cortex in MCI, whereas 
recollection deficits have been related to hippocampal atrophy (Westerberg et al., 2013; Wolk 
et al., 2011). Subsequently neuropathological changes slowly spread to other cortical areas in 
the temporal and frontal lobes. 
Because the different structures of the MTL all appear to play a role in novelty and 
because these structures are impaired early in the course of AD, it would be expected that 
novelty responses will be reduced compared to those of healthy subjects. These changes may 
differ however depending on the stage of the disease. For this reason, we provide in the 
following sections the MMSE (Mini-Mental State Examination; Folstein et al., 1975) of the 
groups of patients whenever available.  
 
3.2 Dopamine in AD 
Although it may have gone long unnoticed, the dopamine system may be disrupted early in 
AD. In a review, Martorana and Koch (2014) concluded that dopamine levels are associated 
with cognitive impairment in AD, although the pathogenic mechanisms leading to 
dysfunction of the dopaminergic system and the time course across the disease need to be 
clarified. Nobili et al. (2017) identified dopaminergic neuronal loss specifically in the VTA in 
a mouse model of AD at the pre-plaque stage, therefore at a relatively early stage of the 
disease. The progression of VTA dopaminergic neuronal death correlated furthermore with 
hippocampal plasticity impairment and decreased memory performance. 
It follows that increasing dopamine levels in patients with AD could possibly restore 
memory functions. This hypothesis was tested by Koch et al. (2014) who administered 
rotigotine, a dopamine agonist, to AD patients (MMSE ranging from 18 to 24). Although the 
patients showed impaired cortical LTP-like activation at baseline as assessed by intermittent 
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theta burst stimulation, this LTP-like level was restored and normalized after rotigotine 
administration, further supporting a role of dopamine in AD, most notably in relation to LTP 
plasticity. Moreover, the restoration of dopaminergic transmission has been demonstrated to 
play a role in memory and learning in a mouse model of AD (Ambree et al., 2009; Guzmán-
Ramos et al., 2012). 
Overall, dopamine levels may be decreased in AD and this may affect the 
hippocampus and memory. These findings further suggest that novelty, which triggers 
dopamine-related LTP in the hippocampus in the healthy brain, could be dysfunctional in AD. 
AD entails neurobiological changes affecting different parts of the neural system supposed to 
support novelty processing. Consequently, one should observe reduced novelty responses in 
AD patients already at the prodromal stage. We will now review the extant data relative to 
novelty processing in AD and MCI. 
 
3.3 Electrophysiological responses to novelty in AD 
Using an oddball paradigm thought to reflect contextual novelty detection, Daffner et al. 
(2001) showed the amplitude of the novelty P3 to be smaller in AD patients (MMSE: mean = 
24, SEM = 1) compared with healthy older adults. Accordingly, Lee et al. (2013) also showed 
decreases in the amplitude of the novelty P3, which appeared to be correlated with the 
deterioration of language, memory and executive function observed in AD patients (MMSE, 
16.1 ± 5.2). A recent meta-analysis (20 studies, 646 subjects, mean MMSE per study ranging 
from 16.2 to 24.0; median: 20.2) performed by Hedges et al. (2016) confirmed reduced P3 
amplitude in patients with mild AD. This finding was corroborated in another meta-analysis 
that found increased P3 latency in patients with mild AD (Howe et al., 2014). Interestingly, 
this study also included a subanalysis of 8 studies focusing on patients with MCI. The latency 
of the P3 was also found to be increased in this group, although with a smaller effect size than 
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in the mild AD group (0.78 vs. 0.99), suggesting a progressive impact of the disease on 
novelty as indexed by the P3. Electrophysiological responses to novelty thus appear to 
progressively change during the course of AD. 
 
3.4 Neuroimaging correlates of novelty in AD 
A few fMRI studies have examined cerebral activations during the encoding of novel stimuli 
compared to the encoding of repeated stimuli.  
 
3.4.1 Stimulus novelty 
In one study in mild to moderate AD patients, Golby et al. (2005; see also Rombouts et al., 
2000) reported less MTL activation in response to novel scenes (MMSE: 18–23, mean 20.8) 
compared with controls. Moreover, smaller MTL novelty responses correlated with poorer 
subsequent explicit memory for the novel scenes. 
 
3.4.2 Associative novelty 
Whereas healthy older participants activated the hippocampus and entorhinal cortex for novel 
face-name pairs more than for repeated face-name pairs, mild to moderate AD patients (mean 
MMSE: 21 ± 3) showed significantly reduced novelty-related hippocampal and entorhinal 
activity (Dickerson et al., 2005; Sperling et al., 2003). Another study (Pihlajamaki et al., 
2011) focused on the repetition suppression response in the hippocampus when novel face-
name pairs are repeated. It showed that, in a group mixing mild AD patients (MMSE: 23 ± 4), 
MCI patients (CDR = 0.5, MMSE: 29 ± 1) and healthy controls, reduced repetition 
suppression was related to subsequently poorer memory for the novel pairs. In MCI patients, 
Dickerson et al. (2005) reported hyperactivation of the hippocampus during encoding of novel 
face-name pairs. Subsequent work exploring this hyperactivation suggests that it arises 
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because of a synaptic dysfunction within the hippocampus (Miller et al., 2008; O'Brien et al., 
2010; Putcha et al., 2011).  
Altogether, fMRI data suggest that the MTL responses to novelty are altered in both 
MCI and AD patients and that this disrupted novelty response is linked with poorer 
subsequent memory for novel stimuli. 
 
3.5 Behavioural correlates of novelty in AD 
An important question is whether patients with AD show behavioural differences compared to 
healthy subjects when they are required to engage in novelty processing. Overall, there has 
been very few direct investigations of the ability of AD patients to detect novelty and/or to 
benefit from the impact of novelty on memory to our knowledge (see Table 2 for main 
findings). We present first results on AD at the dementia stage and then results at earlier 
stages of the disease. 
  
3.5.1 Detection of novelty in AD 
Stimulus novelty 
A small number of studies examined the extent to which AD patients’ attention is attracted to 
novel stimuli by measuring the time spent to view stimuli. In general, visual search times are 
longer in AD, and patients show clear qualitative differences on top-down perceptual tasks 
compared to controls (for a review, see Molitor et al., 2015). Using eyetracking to measure 
viewing time in a visual paired comparison task, Daffner and colleagues (Daffner et al., 1992, 
1999) showed that AD patients spent less time looking at novel incongruous stimuli than 
healthy older participants, and that they distributed their viewing time equally between the 
familiar and the novel incongruous stimuli. This reduced attention to novel items was not 
explained by dementia severity. Daffner et al. (1999) observed some variability among the 
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AD group, with some patients showing a residual attraction to novel stimuli, whereas others 
showed no sign of attention to novelty. These two subgroups did not differ in the ability to 
explicitly report stimuli as novel. The only difference between these subgroups was that the 
patients who were indifferent to novelty were judged as more apathetic in everyday life by 
their informants than the patients with residual attention to novelty. A further study by Chau 
et al. (2015) measured mild to moderate AD patients’ novelty preference (MMSE: 22.2 ± 4.0) 
using eyetracking in a visual paired comparison paradigm. They showed that patients spent 
more time viewing the familiar than the novel pictures compared with controls, and shorter 
fixation times for novel pictures were associated with lower score on the MMSE (Chau et al., 
2015) as well as steeper cognitive decline in subsequent years (Chau et al., 2017).  
 
Contextual novelty 
Using an oddball paradigm, Daffner et al. (2001) examined ERPs associated with the 
processing of repeated and novel line drawings in healthy older adults and mild AD patients 
(MMSE: 24 ± 1). Participants decided how long they viewed each picture. Similar to 
eyetracking data, AD patients did not spend more time looking at novel stimuli than familiar 
ones, contrary to controls. Moreover, in the AD group, the novelty P3 effect was reduced. 
Interestingly, the amplitude of the novelty P3 effect predicted how much time patients spent 
looking at novel pictures. Reduced novelty P3 amplitude was also associated with apathy in 
AD patients.  
 
3.5.2 Novelty - insights from repetition priming 
At its most basic, novelty detection in the human memory system hinges on the ability to 
detect whether a stimulus has been encountered before. The central aim of research into 
repetition priming is to examine how the nervous system responds to repeated stimuli. In 
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priming studies, the explicit awareness of repetition is not the focus of study, but the 
facilitated processing of a stimulus seen for a second time. A crucial distinction is between 
repetition and conceptual priming, with differences between the two seen in Alzheimer’s 
disease (e.g., Keane et al., 1991; Vaidya et al., 1999). Here we focus briefly on repetition 
priming since critically for our aims, intact repetition priming could be interpreted as related 
to novelty processing: something occurs differently in the cognitive system for a stimulus 
seen for the first time than for a repetition. In a review, Fleischman (2007) suggested that 
changes in priming were not part of the healthy aging process, but that when priming is 
impaired in older groups it points to a pathological process. However, they did not find a 
uniform decline in priming in Alzheimer’s disease and MCI. Rather, tasks which involved 
identification - such as picture naming, and word naming - showed intact priming in 
Alzheimer’s disease and MCI. It was only where production was required, such as with stem-
completion tasks, where there were differences between healthy and pathological groups. 
More recently, Ober and Shenaut (2014) used a lexical decision task and showed 
intact repetition priming for words; people with Alzheimer’s disease (MMSE range: 12–28) 
showed the appropriate facilitation in reaction time the second time they encountered a word. 
In addition, in their task, nonwords were also repeated. In such cases, a performance 
decrement (slowing) is expected for word-like nonwords, since being recently activated they 
become similar to real words (e.g., McKoon and Ratcliff, 1979). Ober and Shenaut (2014) 
showed this negative priming effect (i.e., novel stimuli) in their AD patients. They argue that 
this shows that people with AD are able to construct a representation of a novel stimulus 
which then - at least implicitly - has consequences for further processing. The slowing of 
processing - in healthy participants and AD alike - is an interesting one because it points to a 
confusion whereby a novel nonword is difficult to distinguish from a real word due to the fact 
that it is has been recently activated.  
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The sensitivity to repetition in AD, however, is not uniformly preserved. Evidence of 
preserved repetition priming effects in AD patients contrasts with fMRI data showing reduced 
hippocampal repetition suppression in MCI and AD patients (Pihlajamaki et al., 2011), 
outlined above. In the context of repeated study-test trials in an explicit task, AD patients have 
been found to appropriately allocate longer time to study novel items (i.e. words presented for 
the first time) in comparison to items shown twice or three times (Moulin et al., 2000) - which 
could be taken as an appropriate sensitivity to repetition. Critically, however, explicit ratings 
did not discriminate between frequencies of presentation: people with AD allocate longer 
study time to encode items seen the first time, but they do not judge items seen multiple times 
as being any more easy to remember. On the whole, these findings suggest that AD patients 
may have some preserved capacity to identify novelty at an implicit level. Taken with the 
reduced hippocampal repetition suppression, we might propose an intact processing of 
repetition according to standard implicit behavioural measures, but an inappropriate 
processing of novel stimuli in the context of explicit memory, which we review next. In short, 
there is a dysfunctional neural response to repetition in the temporal lobe and a failure to be 
aware of repetition in an explicit memory task. 
 
3.5.3 Novelty and explicit memory in AD 
Novelty-related memory effect 
Only a few studies have directly tested whether AD patients learn novel information better 
than familiar information. Lekeu et al. (2003) used Tulving and Kroll’s (1995) paradigm to 
investigate recognition of familiarized versus novel words in patients with mild AD (mean 
MMSE: 22 ± 4) and controls. Both patients and controls showed greater recognition accuracy 
for novel than familiar words, which indicates a residual novelty effect in AD. Nevertheless, 
AD patients had poorer recognition performance, due to a higher false alarm rate for 
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unstudied words in the novel condition compared with controls. This study also showed that, 
in patients, recognition of novel words correlated with metabolism in the right anterior 
hippocampus. This suggests that the capacity to take advantage of novelty to improve 
memory encoding is related to the integrity of the hippocampus, consistent with 
neurobiological models that emphasize its central role in novelty effects on memory.  
Vitali et al. (2006) evaluated whether mild AD patients (MMSE range: 20-28, mean: 
23 ± 2) demonstrated the von Restorff effect in a task where distinctiveness was created by 
presenting words in a different font size than the others. Healthy older participants recalled 
more distinctive words than non-distinctive words, but there was no effect in AD patients. 
Intriguingly, no AD patients noticed that some words had a bigger font, raising the possibility 
of a contribution of visuoperceptual impairment to the disappearance of the von Restorff 
effect. Furthermore, there was no correlation between sensitivity to novelty and overall 
memory performance, indicating that the absence of the novelty effect on memory was not 
related to the memory impairment itself. Recently, Vallet et al. (2017) also showed that mild 
to moderate AD patients (MMSE range: 18-27) did not display better memory for isolated 
items (a small number of pictures presented on a yellow background) compared to non-
isolated items (many pictures on a white background). In light of the retrieval cue hypothesis 
(Nairne, 2006), it may be that AD patients failed to benefit from the reduced interference 
linked to the novel retrieval cue compared to control items, possibly because less control 
items competed at retrieval. 
Other pieces of evidence relative to novelty-related memory effects in AD come from 
the study of serial position effects in list recall tasks. Whereas the recency effect (i.e., better 
recall of the last items of the list) appears preserved in AD (mild to moderate AD: mean 
MMSE, 19 ± 5; very mild AD: mean MMSE, 25 ± 1), the primacy effect is severely 
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diminished in the patients (Bayley et al., 2000; Cunha et al., 2012). This suggests that AD 
patients fail to benefit from the contextual novelty of the first items of the list. 
 
3.5.4 Novelty detection in the early course of Alzheimer’s disease 
Most studies conducted in the dementia stage of AD, though scarce, suggest that AD patients 
fail to orient attention to novel stimuli and do not benefit from the novelty of an item to 
encode and remember it better than familiar items, even though some residual effect can be 
detected in some patients. However, as Alzheimer pathology starts decades before dementia 
symptoms arise, it would be of great interest to determine when novelty detection begins to be 
impaired. Currently, there is limited information regarding novelty detection in the pre-
dementia stages of AD. 
However, in healthy aging, it seems that there is a decreased responsiveness to novelty 
and an altered processing of rare targets (e.g., Fabiani and Friedman, 1995). More recent 
evidence, in contrast, supports the idea that older participants are heterogeneous in their 
response to novelty and that decreased attention to novelty is not the rule during the aging 
process. For example, Daffner et al. (2006; 2007) showed that older adults with high 
performance on attention and executive function tests spent more time looking at novel items 
in pairs and demonstrated a larger novelty P3 ERP effect than older adults with poorer 
neuropsychological performance. In the framework of the cognitive reserve hypothesis (Stern, 
2009), high-performing older adults are less likely to develop dementia than low-performing 
older adults. Although this is speculative, Daffner et al.’s (2006, 2007) results could mean that 






In MCI, the existing data point to relatively preserved stimulus novelty detection under some 
conditions, with an emergence of a decreased sensitivity to novelty when task demands 
increase. For instance, Crutcher et al. (2009) used the visual paired comparison paradigm in a 
small sample of 6 MCI patients. By measuring viewing time with eyetracking, the authors 
showed that, when encoding and recognition were separated by a 2-second delay, the MCI 
patients and control participants performed comparably, viewing the novel picture 71% of the 
time. However, when the study-test delay increased to 2 minutes, MCI patients viewed the 
novel picture only 53% of the time, while control participants remained above 70%. This 
reveals that the orientation of attention to novelty diminishes in MCI when the novel status of 
an item must rely on long-term memory. In contrast, immediate orienting of attention to 
novelty, when memory load is limited, is preserved in MCI. 
Yeung et al. (2013) also used eyetracking measures of the number of fixations to 
repeated and novel objects in a continuous passive viewing task. The novel objects were 
either relatively different from or very similar to previously presented ones. The populations 
studied were older participants at risk for AD (below cut-off MoCA score), healthy older 
participants and young participants. Both young participants and healthy older adults made 
more fixations to the two kinds of novel objects compared to studied objects. In contrast, 
older participants at risk for AD showed normal eyetracking behaviour towards novel stimuli 
that were different from studied ones, but made significantly less fixations to novel stimuli 
that were very similar to studied objects. In other words, these participants automatically 
processed these novel items as if they were familiar. These findings speak to a novelty 
detection impairment in individuals at risk for AD only when novelty is subtle and concerns 
very fine perceptual discrimination.  
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Novelty-related memory effect 
In immediate free recall tasks, MCI patients, like AD patients, have a diminished primacy 
effect (Howieson et al., 2011). Moreover, the impaired primacy effect predicts whether a MCI 
patient will develop dementia in the following years or not (Cunha et al., 2012). Therefore, 
the contextual novelty of the first items of the list does not help the patients to remember 
those items better and such difficulty may be an early sign of future AD. Furthermore, in 
MCI, the primacy effect in delayed recall of a word list correlated with functional 
connectivity between the hippocampus and several brain regions including temporal, frontal 
and middle cingulate cortex and the thalamus (Brueggen et al., 2016). Finally, Belleville et al. 
(2011) evaluated recognition memory performance of MCI patients and controls after an 
encoding phase where familiar items (i.e., words) and novel items (i.e., pseudowords) were 
presented. This task did not yield any novelty-related memory effect, as memory was better 
for familiar than for novel items. MCI patients showed impaired recognition memory for 
familiar items, accompanied by a decrease in recollection of these items, but their recognition 
performance for novel items did not differ from that of the controls. Although the task failed 
to yield a memory benefit for novelty, it nevertheless reported preserved memory for novel 
items in MCI. 
In brief, novelty detection and novelty-related memory effects may be relatively 
preserved in people with MCI, except when task demands are high. Nevertheless, there is 
little or no evidence that the populations included in these studies are actually in a prodromal 
stage of AD based on currently used amyloid biomarkers. Therefore, currently available data 
cannot truly ascertain the status of novelty detection and processing in the earliest phase of 
AD. The only piece of evidence suggesting that impaired novelty processing could predict 
future dementia comes from the study by Cunha et al. (2012) on the primacy effect. 
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4. Outstanding questions 
We review here questions that need to be addressed in the near future (summary in Table 3). 
 
4.1 Identifying the patterns of impairments across different types of novelty 
Most current data suggest that patients in the dementia stage of AD fail to orient attention to 
novel stimuli and do not benefit from novelty during memory tasks. The different studies have 
however each focused on one type of novelty, and relationships with cerebral changes have 
rarely been explored. In order to fully establish the status of novelty detection and processing 
in AD, a systematic investigation of all types of novelty within the same sample of AD 
patients is warranted. Related to this idea, given that stimulus—, contextual— and associative 
novelty rely on distinct MTL regions, one could expect that they are independently affected as 
a function of the stage of the disease and the extent of cerebral changes to the MTL regions in 
the patients. Differential progression of neurofibrillary tangles across the entorhinal cortex, 
perirhinal cortex and hippocampus would presumably lead to different trajectories of 
degradation of the different types of novelty processing. Moreover, the additional contribution 
of prefrontal pathology, which arises during the course of AD (Salat et al., 2001), should be 
considered as it might impact attentional orientation to novelty (Daffner et al., 2000b) and 
assessment of the importance of novel events to guide their encoding (Lisman and Grace, 
2005). 
 
4.2 Establishing the link between novelty and memory impairment during the time course of 
AD 
An important related question is how changes to novelty detection relate to changes in 
declarative memory functioning, especially recollection and familiarity, along the 
chronological course of AD. This may notably help to contribute to answer to the question of 
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the relationship between novelty and familiarity (see section 2.3). In classical recognition 
memory tasks, old and new stimuli have to be discriminated. Rejection of new stimuli is 
sometimes taken as an index of novelty effects (stimulus novelty in single item recognition 
memory and associative novelty in association recognition memory), while endorsement of 
old items would rely on familiarity (e.g., de Chastelaine et al., 2017; Kafkas and Montaldi, 
2014). In MCI and AD, higher rates of false recognition of new items (Budson et al., 2003) 
and of recombined pairs (Gallo et al., 2004; Genon et al., 2013; Troyer et al., 2012) could be 
taken as evidence of poor detection of stimulus and associative novelty, respectively. In 
parallel, familiarity-based recognition memory, defined by opposition to recollection, may be 
the first memory function to decline (Besson et al., 2015; Didic et al., 2011; Wolk et al., 
2013), although this is debated (for reviews, Koen and Yonelinas, 2014; Schoemaker et al., 
2014). If novelty and familiarity are the two ends of a single continuum (Brown and Bashir, 
2002; Fernandez and Tendolkar, 2006; Grill-Spector et al., 2006; Horner et al., 2012), one 
may expect that novelty starts to decline at the same time as familiarity. In contrast, if novelty 
detection and familiarity are independent functions (de Chastelaine et al., 2017; Kafkas and 
Montaldi, 2014), one may see them change along different time courses as the pathology 
progresses. These hypotheses clearly require future work. One challenge will be to create 
tasks that allow to assess separately novelty and familiarity, as recognition memory tasks 
intermix both (de Chastelaine et al., 2017). 
 
4.3 Exploring the impact of the dopaminergic neuromodulation system on novelty and 
memory in AD 
One intriguing possibility could be that, in MCI, immediate orientation of attention by novelty 
is preserved, but the interaction between novelty and memory is altered (Crutcher et al., 
2009). Thus, a key point that deserves further investigation is the dopaminergic 
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neuromodulation system at the different stages of AD. How well does the hippocampus-VTA 
loop function in the preclinical, prodromal and dementia stages of AD? How does this relate 
to novelty effects? Such questions would need to be answered in order to fully understand 
behavioural novelty-related effects and their cerebral underpinnings. One way to approach 
these questions would be to correlate novelty effects with indirect measures of dopaminergic 
activation in patients, such as eye movements, which have been shown to track dopaminergic 
activity (Blin et al., 1990; Karson, 1983; Taylor et al., 1999). Further combining these 
measures with fMRI assessment of functional connectivity between the hippocampus and 
VTA would provide indication as to changes in the novelty-related neurobiological system as 
AD pathology progresses. If there is some residual functioning within this system, it could in 
principle be possible to improve novelty detection by pharmacological manipulation of 
dopamine in patients. A related, important, question suggested by some studies (Daffner et al., 
1999) is whether only a subgroup of patients with AD show additional complications due to 
impairment to the dopaminergic system rather than all patients showing dopaminergic 
impairment in the course of the disease. It seems critical to study whether such a subgroup 
exists as it may be the target of specific clinical trials. 
 
4.4 Determining the clinical correlates of novelty in AD 
As well as links with memory and learning, there are undoubted links between novelty 
processing and other real-world behaviours in AD patients, such as apathy and personality 
changes. Apathy, i.e. loss of motivation, curiosity and interest/engagement in new events, is 
one of the most commonly experienced neuropsychiatric symptoms in AD (Robert et al., 
2009). Daffner et al. (1999) showed that AD patients who failed to demonstrate exploratory 
eye-movements to novel items were rated by informants as being more apathetic than AD 
patients with normal visual fixation to novelty. In this context, one issue that deserves further 
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investigation is whether the link between indifference to novelty, poor memory and clinical 
changes, such as apathy in everyday life, could indicate that common neurobiological 
mechanisms underlie both symptoms. Lack of visual exploration presumably underpins a 
number of critical real-world behaviours, including the exploration of facial emotion. 
Consistently, Ogrocki et al. (2000) showed that AD patients could explicitly discriminate 
facial emotions as effectively as controls, but their eye-movements differed, spending 
proportionately longer time on irrelevant areas of the face. Also indicating alteration of 
curiosity, there is some evidence that people with AD allocate less looking time to 
incongruous parts of an image (e.g. a horse with its hind legs missing; Daffner et al., 1992), 
and tend to ‘overlook’ unusual parts of an image (Moser et al., 1995). Although explicit 
measures of curiosity exist, whereby participants rate their subjective experience of desire to 
find out currently unknown information (e.g., Litman, 2005), there has, to our knowledge, 
been no attempt to take such measures in AD. 
Moreover, novelty seeking is a key factor in the personality dimension of openness, 
according to the ‘big-five’ personality schedule (Costa and McCrae, 1992). Interestingly, 
Robins Wahlin and Byrne (2011) pinpoint a marked reduction in openness scores in 
Alzheimer’s disease. A measure of novelty seeking using scales such as the tridimensional 
personality questionnaire (Cloninger et al., 1991) could be useful to understand individual 
variability in the response to novelty and to identify how AD modifies such personality traits.  
 
4.5 Manipulating novelty to improve memory in AD 
Even if current studies mostly point to impaired novelty processing in AD, the existence of 
residual effects in some cases opens the door to using novelty in rehabilitation programs. It 
remains possible that improving the novelty of a stimulus or triggering the novelty system 
could be beneficial in AD. Better understanding the trajectories of changes to the different 
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kinds of novelty across the AD spectrum would allow us to determine how and when one can 
improve learning by manipulating saliency, using approaches such as the von Restorff 
paradigm, or by activating the novelty system (Schomaker et al., 2014). Alternatively, 
stimulation of the novelty neurobiological system may be achieved by pharmaceutical 
modulation of dopaminergic activity, as mentioned earlier. Given that novelty seems to be 
impaired in the dementia stage of AD, we do not expect that it can be restored fully to the 
level of efficiency of healthy subjects. However, a relative benefit might be observed (e.g., 
increased memory for stimuli presented using a novelty paradigm compared to stimuli 
presented in familiar condition). In the earlier stage (prodromal AD), when novelty processing 
is less affected, the benefit could be even larger and lead to a strong impact on everyday life 
memory functioning. Studies thus need to be performed to verify if promoting novelty could 
enhance, at least relatively, memory in patients with AD. This could open a new avenue into 
memory support programs for both clinicians and people taking care of patients with MCI and 
AD. 
 
5. A novel model of memory impairment in Alzheimer’s disease 
More broadly, a possibility is that taking into account novelty might be highly beneficial to 
conceptualize better models of the memory impairment in AD. Although AD patients’ 
memory difficulties are commonly directly linked to medial temporal lobe impairment in 
relation to tau pathology (Barbeau et al., 2012; Bastin et al., 2010, 2014; Didic et al., 2011; 
Genon et al., 2012), a different line of research, originating mainly from resting state 
neuroimaging, has emphasized the role of impaired networks with regards to amyloid 
pathology to account for the memory impairment observed in this disease (Nestor et al., 2006; 
Sperling et al., 2014). This network includes a set of medial cortical regions such as the 
posterior cingulate and medial prefrontal cortices. However, given our review above, it is 
 31 
timely to include novelty as another source of memory dysfunction in AD. Altogether, these 
three sources of impairment (summarized in Figure 5) could explain the severe memory 
alteration seen in AD. Such a model, by proposing an integrative vision of the memory 
impairment in AD could yield a more complete view of preserved and impaired capacities in 
the course of the disease and offer opportunities for better rehabilitation. It could also explain 
the heterogeneity of memory disorders observed in this disease depending on the relative 
impairment of each source of memory deficit (Barbeau et al., 2006). It is also likely that 
future work will be able to unravel the dynamics of the contribution of each source of 
memory impairment at different stages of the disease.  
Last, but not least, this model puts forward the idea that neurotransmitters, such as 
dopamine in the present case, may be involved in memory dysfunction in AD. However other 
neurotransmission systems, such as the noradrenergic and cholinergic systems, have for long 
been known to be impaired in AD and are also involved in memory and novelty (Bunzeck et 
al., 2014; Caldenhove et al., 2017). Altogether, this model offers a more realistic view of the 
memory impairment seen in AD, including local effects on brain structures directly involved 
in memory such as the MTL, network effects on brain structures such as the posterior 
cingulate and medial prefrontal areas (La Joie et al., 2012) and effects due to neurotransmitter 
systems.  
This review indicates that novelty processing is impaired in AD, probably impacting 
memory from an early stage. We have consequently provided a novel model to explain 
memory impairment throughout the course of AD disease. We suggest that a better 
understanding of novelty impairment in AD is a critical step towards targeted rehabilitation 
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Figure 1. Illustration of the oddball paradigm (left) and of the von Restorff paradigm (right). 
In this version of the von Restorff paradigm, an item, the isolate, is made distinct using a 
different colour for the font, leading to a perceptual novelty effect. 
Figure 2. Three classes of models of novelty detection relatively to familiarity detection. See 
text for a detailed description. 
Figure 3. ERPs recorded in the hippocampus of epileptic patients undergoing intracerebral 
recordings in the context of preneurosurgical evaluation (mean ERPs across 5 subjects). The 
ERP evoked by oddball stimuli to which subjects attended (blue) induce a large response in 
the hippocampus peaking around 400ms. In contrast, irrelevant, frequent, stimuli (green) 
presented during the oddball task do not induce any ERP. The same set of stimuli, including 
oddballs (brown), presented to the subjects while they did not have to pay attention to them do 
not induce any component, suggesting that the hippocampus is involved in endogenous 
attention to novel stimuli. 
Figure 4. Schematic representation of the hippocampal-VTA loop supporting encoding of 
novel stimuli (after Lisman & Grace, 2005) 
Figure 5. A novel proposition explaining memory impairment in Alzheimer’s disease, taking 
into account each putative source of impairment: medial temporal lobe lesions due to tau 
pathology, medial cortical network impairment associated with amyloid pathology, such as 
the abnormalities robustly observed in the posterior cingulate gyrus in AD and novelty 
impairment due to both medial temporal lobe and dopaminergic dysfunctions. These various 
sources of memory impairment could accumulate and explain the severe, and typical, memory 
impairment seen in AD. It could also explain the variety of memory impairments presentation 
observed in this disease.  
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Table 1. List and definitions of specific terms used in this review article 
Term Definition 
Associative novelty A novel configuration or combination of familiar stimuli 
Contextual novelty A familiar stimulus that is unexpected in a given context 
Distinctiveness A familiar stimulus that stands out from others in a series 
Orienting response An organism’s immediate reaction to changes in the environment, irrespective 
of the intensity or the quality of the novel information 
P3 An event-related brain potential (ERP) correlate of the evaluation of 
contextual novelty 
Priming Facilitated processing when a stimulus is repeated 
Primacy effect Enhanced memory for first items in a list 
Repetition 
suppression 
Decreased neural activity related to the progressive familiarization of a novel 
stimulus 
Stimulus novelty An unfamiliar stimulus or stimulus that has never been experienced before 
Surprise The violation of expectancies or the deviation from explicit prediction. The 
critical issue is of a deviance from an anticipated event or stimulus, rather 
than a contextually novel stimulus, such as an unexpected sequence, rather 
than a novel single stimulus (see Schomaker and Meyer, 2015 for 




Table 2. Main findings on novelty processing in AD and in individuals at risk for AD. VPC: 
Visual Paired Comparison. 
 In AD In individuals at risk for AD 
Stimulus novelty 
 Decreased viewing time to novel 
stimuli (Chau et al., 2015), 
associated with apathy (Daffner et 
al., 1992, 1999).  
 
 
MCI: Decreased viewing time to novel 
stimuli in VPC, only if study-test delay of 2 
min (Crutcher et al., 2009) 
 
At risk healthy older: Reduction of 
fixations to novel items that are similar to 
studied items, but preserved novelty 
response to dissimilar novel items (Yeung 
et al., 2013). 
Contextual novelty 
  Reduced novelty P3 in an 
oddball task (Daffner et al., 
2001). 
 
Novelty-related memory effects 
 Reduced primacy effect in list 
recall (Bayley et al., 2000; Cunha 
et al., 2012). 
 MCI: reduced primacy effect predicts 
progression to AD (Cunha et al., 2012). 
 Disappearance of the von Restorff 
effect with perceptual 
distinctiveness (Vallet et al., 
2017; Vitali et al., 2006) 
 
 Diminished, but not abolished, 
benefit of memory for novel over 
familiarized items; related to 
hippocampal integrity (Lekeu et 
al., 2003) 
MCI: intact recognition memory for novel 





Table 3. Outstanding questions remaining to be clarified about AD and novelty processing. 
1. What is the pattern of impairment associated with AD across the different types of 
novelty? 
2. Is novelty processing impaired following the same time course as memory in AD? Is it 
impaired at the prodromal stage of AD? Does it decline at the same rate as familiarity? 
3. What is the impact of the dopaminergic neuromodulation on memory in AD? 
4. Is there a link between novelty detection and apathy or novelty seeking in AD? 
5. Can novelty be used to improve memory in AD? 
 
 
 
 
